References
- AbramovAYCanevariLDuchenMR2004Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in cultureBiochim Biophys Acta174281715590058
- AmbroggioEEKimDHSeparovicF2005Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1–42: a membrane-disrupting peptideBiophys J8827061315681641
- AnandatheerthavaradaHKBiswasGRobinMA2003Mitochondrial targeting and a novel transmembrane arrest of Alzheimer’s amyloid precursor protein impairs mitochondrial function in neuronal cellsJ Cell Biol161415412695498
- ArancioOZhangHPChenX2004RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic miceEmbo J23409610515457210
- ArendtT2003Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the ‘Dr Jekyll and Mr. Hyde concept’ of Alzheimer’s disease or the yin and yang of neuroplasticityProg Neurobiol718324814687983
- ArispeNRojasEPollardHB1993Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminumProc Natl Acad Sci U S A90567718380642
- ArnoldSEHymanBTFloryJ1991The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s diseaseCereb Cortex1103161822725
- BakerMMackenzieIRPickering-BrownSM2006Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature442916916862116
- BarghornSNimmrichVStriebingerA2005Globular amyloid beta-peptide oligomer – a homogenous and stable neuropathological protein in Alzheimer’s diseaseJ Neurochem958344716135089
- BhatiaRLinHLalR2000Fresh and globular amyloid beta protein (1–42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicityFaseb J1412334310834945
- BiXGallCMZhouJ2002Uptake and pathogenic effects of amyloid beta peptide 1–42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonistsNeuroscience1128274012088742
- BolmontTClavagueraFMeyer-LuehmannM2007Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic miceAm J Pathol17120122018055549
- BraakHBraakE1991Neuropathological stageing of Alzheimer-related changesActa Neuropathol (Berl)82239591759558
- BraakHBraakE1995Staging of Alzheimer’s disease-related neurofibrillary changesNeurobiol Aging162718 discussion 8–847566337
- BraithwaiteSPPaulSNairnAC2006Synaptic plasticity: one STEP at a timeTrends Neurosci29452816806510
- CappaiRBarnhamKJ2008Delineating the mechanism of Alzheimer’s disease A beta peptide neurotoxicityNeurochem Res335263217762917
- CasasCSergeantNItierJM2004Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic modelAm J Pathol165128930015466394
- CaspersenCWangNYaoJ2005Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s diseaseFaseb J192040116210396
- ChenFDavidDFerrariA2004aPosttranslational modifications of tau - Role in human tauopathies and modeling in transgenic animalsCurr Drug Targets55031515270197
- ChenFWollmerMAHoerndliF2004bRole for glyoxalase I in Alzheimer’s diseaseProc Natl Acad Sci U S A10176879215128939
- ChinJPalopJJYuGQ2004Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic miceJ Neurosci244692715140940
- ChongYHShinYJLeeEO2006ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice culturesJ Biol Chem281203152516714296
- ClearyJPWalshDMHofmeisterJJ2005Natural oligomers of the amyloid-beta protein specifically disrupt cognitive functionNat Neurosci8798415608634
- CoulsonEJ2006Does the p 75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer’s disease?J Neurochem986546016893414
- CrouchPJBlakeRDuceJA2005Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1–42J Neurosci25672915659604
- CrutsMGijselinckIvan der ZeeJ2006Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Nature442920416862115
- DavidDHoerndliFGotzJ2005aFunctional Genomics meets neurodegenerative disorders Part I: Transcriptomic and proteomic technologyProg Neurobiol761536816168556
- DavidDCHauptmannSScherpingI2005bProteomic and functional analysis reveal a mitochondrial dysfunction in P301L tau transgenic miceJ Biol Chem280238021415831501
- DavidDCIttnerLMGehrigP2006β-Amyloid treatment of two complementary P301L tau-expressing Alzheimer’s disease models reveals similar deregulated cellular processesProteomics665667717111439
- De FeliceFGVelascoPTLambertMP2007Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantineJ Biol Chem2821159060117308309
- DeaneRWuZSagareA2004LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoformsNeuron433334415294142
- DelacourteASergeantNChampainD2002Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s diseaseNeurology5939840712177374
- DemuroAMinaEKayedR2005Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomersJ Biol Chem2801729430015722360
- DetersNIttnerLMGotzJ2008Divergent phosphorylation pattern of tau in P301L tau transgenic miceEur J Neurosci281374718662339
- DeviLPrabhuBMGalatiDF2006Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunctionJ Neurosci2690576816943564
- EckertADroseSBrandtU2008aOligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic miceJ Mol Med8612556718709343
- EckertAHauptmannSScherpingI2008bSoluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic miceNeurodegener Dis5157918322377
- EdbauerDWinklerERegulaJT2003Reconstitution of gamma-secretase activityNat Cell Biol5486812679784
- FerrariAHoerndliFBaechiT2003Beta-amyloid induces PHF-like tau filaments in tissue cultureJ Biol Chem27840162812893817
- GamesDAdamsDAlessandriniR1995Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein [see comments]Nature37352377845465
- GlennerGGWongCW1984Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochem Biophys Res Commun120885906375662
- GoedertMWischikCMCrowtherRA1988Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tauProc Natl Acad Sci U S A85405153131773
- Gomez-RamosPAsuncion MoranM2007Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brainsJ Alzheimers Dis1153917361035
- GotzJ2001Tau and transgenic animal modelsBrain Res Brain Res Rev352668611423157
- GotzJChenFBarmettlerR2001aTau filament formation in transgenic mice expressing P301L TauJ Biol Chem2765293411013246
- GotzJChenFvan DorpeJ2001bFormation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta42 fibrilsScience2931491511520988
- GotzJDetersNDoldissenA2007A decade of tau transgenic animal models and beyondBrain Pathol179110317493043
- GotzJIttnerLM2008Animal models of Alzheimer’s disease and frontotemporal dementiaNat Rev Neurosci95324418568014
- GotzJIttnerLMFandrichM2008Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods?J Alzheimers Dis14423918688093
- GotzJIttnerLMKinsS2006Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer’s disease?J Neurochem98993100616787410
- GotzJNitschRM2001Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic miceNeuroreport1220071611435938
- GotzJProbstASpillantiniMG1995Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoformEmbo J141304137729409
- GotzJSchildAHoerndliF2004aAmyloid-induced neurofibrillary tangle formation in Alzheimer’s disease: insight from transgenic mouse and tissue-culture modelsInt J Dev Neurosci224536515465275
- GotzJStrefferJRDavidD2004bTransgenic animal models of Alzheimer’s disease and related disorders: Histopathology, behavior and therapyMol Psychiatry96648315052274
- GotzJTolnayMBarmettlerR2001cOligodendroglial tau filament formation in transgenic mice expressing G272V tauEur J Neurosci1321314011422454
- Graff-RadfordNRWoodruffBK2007Frontotemporal dementiaSemin Neurol27485717226741
- HabichtGHauptCFriedrichRP2007Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrilsProc Natl Acad Sci U S A10419232718042730
- HardyJSelkoeDJ2002The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeuticsScience297353612130773
- HarperJDLansburyPTJr1997Models of amyloid seeding in Alzheimer’s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteinsAnnu Rev Biochem663854079242912
- HartleyDMWalshDMYeCP1999Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neuronsJ Neurosci1988768410516307
- HoerndliFDavidDGotzJ2005Functional genomics meets neurodegenerative disorders. Part II: Application and data integrationProg Neurobiol761698816169146
- HoerndliFJPelechSPapassotiropoulosA2007Abeta treatment and P301L tau expression in an Alzheimer’s disease tissue culture model act synergistically to promote aberrant cell cycle re-entryEur J Neurosci26607217587323
- HoerndliFJToigoMSchildA2004Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reactionAnal Biochem335304115519568
- HolscherC1998Possible causes of Alzheimer’s disease: amyloid fragments, free radicals, and calcium homeostasisNeurobiol Dis5129419848086
- HortschanskyPSchroeckhVChristopeitT2005The aggregation kinetics of Alzheimer’s beta-amyloid peptide is controlled by stochastic nucleationProtein Sci141753915937275
- HsiaoKChapmanPNilsenS1996Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice [see comments]Science274991028810256
- HuttonMLendonCLRizzuP1998Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17Nature39370259641683
- IshiharaTHongMZhangB1999Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the – human tau isoformNeuron247516210595524
- IttnerLMFathTKeYD2008Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementiaProc Natl Acad Sci U S A105159971600218832465
- IvinsKJBuiETCotmanCW1998Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosisNeurobiol Dis53657810069579
- JanusCPearsonJMcLaurinJ2000A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s diseaseNature4089798211140685
- JichaGABowserRKazamIG1997Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tauJ Neurosci Res48128329130141
- KeilUBonertAMarquesCA2004Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosisJ Biol Chem279503102015371443
- KinsSCrameriAEvansDR2001Reduced PP2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic miceJ Biol Chem2763819320011473109
- KinsSKurosinskiPNitschRM2003Activation of the ERK and JNK signaling pathways caused by neuron specific inhibition of PP2A in transgenic miceAm J Pathol1638334312937125
- KlyubinIWalshDMLemereCA2005Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivoNat Med115566115834427
- KulicLKurosinskiPChenF2006Active immunization trial in Abeta42-injected P301L tau transgenic miceNeurobiol Dis2250616289870
- KurosinskiPGotzJ2002Glial cells under physiologic and pathological conditionsArch Neurol591524812374489
- LambertMPBarlowAKChromyBA1998Diffusible, nonfibrillar ligands derived from Abeta-1 –42 are potent central nervous system neurotoxinsProc Natl Acad Sci U S A956448539600986
- LauTLAmbroggioEETewDJ2006Amyloid-beta peptide disruption of lipid membranes and the effect of metal ionsJ Mol Biol3567597016403524
- LeeGNewmanSTGardDL1998Tau interacts with src-family non-receptor tyrosine kinasesJ Cell Sci1113167779763511
- LeeVMGoedertMTrojanowskiJQ2001Neurodegenerative tauopathiesAnnu Rev Neurosci2411215911520930
- LesneSKohMTKotilinekL2006A specific amyloid-beta protein assembly in the brain impairs memoryNature440352716541076
- LewisJDicksonDWLinW-L2001Enhanced neurofibrillary degeneration in transgenic mice expressing mutant Tau and APPScience29314879111520987
- LimYAIttnerLMLimYL2008Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical culturesFEBS Lett58221889418486611
- LinHBhatiaRLalR2001Amyloid beta protein forms ion channels: implications for Alzheimer’s disease pathophysiologyFaseb J1524334411689468
- LustbaderJWCirilliMLinC2004ABAD directly links Abeta to mitochondrial toxicity in Alzheimer’s diseaseScience3044485215087549
- ManczakMAnekondaTSHensonE2006Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progressionHum Mol Genet1514374916551656
- MastersCLSimmsGWeinmanNA1985Amyloid plaque core protein in Alzheimer disease and Down syndromeProc Natl Acad Sci U S A82424593159021
- MinogueAMSchmidAWFogartyMP2003Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta?J Biol Chem278279718012738769
- MuckeLMasliahEYuGQ2000High-level neuronal expression of abeta 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formationJ Neurosci204050810818140
- NeculaMKayedRMiltonS2007Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinctJ Biol Chem282103112417284452
- NeumannMMackenzieIRCairnsNJ2007TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutationsJ Neuropathol Exp Neurol66152717279000
- NeumannMSampathuDMKwongLK2006Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisScience314130317023659
- PatelVArayaRChatterjeeS2007Treatment and prevention of mental disorders in low-income and middle-income countriesLancet370991100517804058
- PellarinRCaflischA2006Interpreting the aggregation kinetics of amyloid peptidesJ Mol Biol3608829216797587
- PennanenLGotzJ2005Different tau epitopes define Abeta(42)-mediated tau insolubilityBiochem Biophys Res Commun337109710116226718
- PennanenLWelzlHD‘AdamoP2004Accelerated extinction of conditioned taste aversion in P301L tau transgenic miceNeurobiol Dis15500915056457
- PennanenLWolferDPNitschRM2006Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic miceGenes Brain Behav53697916879631
- PeriniGDella-BiancaVPolitiV2002Role of p 75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokinesJ Exp Med1959071811927634
- PikeCJBurdickDWalencewiczAJ1993Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly stateJ Neurosci131676878463843
- PikeCJWalencewiczAJGlabeCG1991aAggregation-related toxicity of synthetic beta-amyloid protein in hippocampal culturesEur J Pharmacol20736781783006
- PikeCJWalencewiczAJGlabeCG1991bIn vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicityBrain Res56331141786545
- PollardHBArispeNRojasE1995Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicityCell Mol Neurobiol15513268719038
- PoorkajPBirdTDWijsmanE1998Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnn Neurol43815259629852
- ProbstAGotzJWiederholdKH2000Axonopathy and amyotrophy in mice transgenic for human four-repeat tau proteinActa Neuropathol (Berl)994698110805089
- RapoportMDawsonHNBinderLI2002Tau is essential to beta-amyloid-induced neurotoxicityProc Natl Acad Sci U S A996364911959919
- RobersonEDScearce-LevieKPalopJJ2007Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse modelScience316750417478722
- RocchiAPellegriniSSicilianoG2003Causative and susceptibility genes for Alzheimer’s disease: a reviewBrain Res Bull6112412788204
- SelkoeDJ2002Alzheimer’s disease is a synaptic failureScience2987899112399581
- ShibataMYamadaSKumarSR2000Clearance of Alzheimer’s amyloid-beta(1–40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrierJ Clin Invest10614899911120756
- SmallDHMokSSBornsteinJC2001OPINION Alzheimer’s disease and Abeta toxicity: from top to bottomNat Rev Neurosci2595811484003
- SmithDPCiccotostoGDTewDJ2007Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer’s disease amyloid-beta peptideBiochemistry4628819117297919
- SnowdenJSBathgateDVarmaA2001Distinct behavioural profiles in frontotemporal dementia and semantic dementiaJ Neurol Neurosurg Psychiatry703233211181853
- SnyderEMNongYAlmeidaCG2005Regulation of NMDA receptor trafficking by amyloid-betaNat Neurosci81051816025111
- SotthibundhuASykesAMFoxB2008Beta-amyloid (1–42) induces neuronal death through the p 75 neurotrophin receptorJ Neurosci283941618400893
- SpillantiniMGMurrellJRGoedertM1998Mutation in the tau gene in familial multiple system tauopathy with presenile dementiaProc Natl Acad Sci U S A957737419636220
- SpittaelsKVan den HauteCVan DorpeJ1999Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau proteinAm J Pathol15521536510595944
- StalderMPhinneyAProbstA1999Association of microglia with amyloid plaques in brains of APP23 transgenic miceAm J Pathol15416738410362792
- StineWBJrDahlgrenKNKrafftGA2003In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesisJ Biol Chem278116122212499373
- Sturchler-PierratCAbramowskiDDukeM1997Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathologyProc Natl Acad Sci U S A9413287929371838
- TakumaKYaoJHuangJ2005ABAD enhances Abeta-induced cell stress via mitochondrial dysfunctionFaseb J19597815665036
- TrommerBLShahCYunSH2005ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1–42Neurobiol Dis18758215649697
- VassarRBennettBDBabu-KhanS1999Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACEScience2867354110531052
- VerdierYZarandiMPenkeB2004Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer’s diseaseJ Pept Sci102294815160835
- WalshDMKlyubinIFadeevaJV2002Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivoNature416535911932745
- WalshDMKlyubinIShankarGM2005The role of cell-derived oligomers of Abeta in Alzheimer’s disease and avenues for therapeutic interventionBiochem Soc Trans3310879016246051
- WangQWalshDMRowanMJ2004Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p 38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5J Neurosci243370815056716
- WederNDAzizRWilkinsK2007Frontotemporal dementias: a reviewAnn Gen Psychiatry61517565679
- WegielJKuchnaINowickiK2007Intraneuronal Abeta immuno-reactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degenerationActa Neuropathol11338940217237937
- WhiteARGuirguisRBrazierMW2001Sublethal concentrations of prion peptide PrP106–126 or the amyloid beta peptide of Alzheimer’s disease activates expression of proapoptotic markers in primary cortical neuronsNeurobiol Dis829931611300725
- WhiteJAManelliAMHolmbergKH2005Differential effects of oligomeric and fibrillar amyloid-beta 1–42 on astrocyte-mediated inflammationNeurobiol Dis184596515755672
- YanSDChenXFuJ1996RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s diseaseNature382685918751438
- YanYLiuYSorciM2007Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interactionBiochemistry4617243117253767
- YanYWangC2007Abeta40 protects non-toxic Abeta42 monomer from aggregationJ Mol Biol3699091617481654
- YanknerBADuffyLKKirschnerDA1990Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptidesScience250279822218531
- ZhangYHongYBounharY2003p 75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicityJ Neurosci2373859412917374